Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Legend Strategy International Holdings Group Co., Ltd. ( (HK:1355) ).
Legend Strategy International Holdings Group Co., Ltd. has agreed, through a purchaser subsidiary, to acquire 100% of Auro Hong Kong Limited for HK$22 million, together with a shareholder loan, which will give it an indirect 37.5% equity stake in Beisheng Biotechnology accounted for under the equity method. The deal, classified as a discloseable transaction under Hong Kong listing rules and not requiring shareholder approval, will make Auro Hong Kong an indirect wholly owned subsidiary, potentially expanding Legend Strategy’s exposure to the biotechnology sector, though completion remains subject to conditions and may not proceed, prompting a cautionary note to investors.
The most recent analyst rating on (HK:1355) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on Legend Strategy International Holdings Group Co., Ltd. stock, see the HK:1355 Stock Forecast page.
More about Legend Strategy International Holdings Group Co., Ltd.
Average Trading Volume: 983,024
Technical Sentiment Signal: Sell
Current Market Cap: HK$139.6M
For an in-depth examination of 1355 stock, go to TipRanks’ Overview page.